a Systematic Review of the Literature Examining the Effects of Cigarette Smoke and e-Cigarette Vapor on the Virulence of human Pathogenic Bacteria.
Nonclinical
Immunotoxicity
In Vivo
Bagale (2022)
Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens.
Nonclinical
Immunotoxicity
In Vivo
Gilpin (2019)
Inflammation and oxidative stress from E-cigarette exposure: implications for COPD and asthma.
Nonclinical
Immunotoxicity
In Vivo
hutchinson (2022)
Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for atherosclerosis.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
Increased Expression of Proatherogenic Proteins in Immune Cell Subtypes in Tobacco Cigarette Smokers But Not in Electronic Cigarette Vapers.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
another Warning Sign: high Nicotine Content in Electronic Cigarettes Disrupts Mucociliary Clearance, the Essential Defense Mechanism of the Lung.
Nonclinical
Immunotoxicity
In Vivo
Kesimer (2019)
Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine.
Nonclinical
Immunotoxicity
In Vivo
Madison (2019)
Chronic E-Cigarette aerosol Inhalation alters the Immune State of the Lungs and Increases aCE2 Expression, Raising Concern for altered Response and Susceptibility to SaRS-CoV-2.
Nonclinical
Immunotoxicity
In Vivo
Masso-Silva (2021)
Metabolome-wide association study of flavorant vanillin exposure in bronchial epithelial cells reveals disease-related perturbations in metabolism.
Nonclinical
Immunotoxicity
In Vivo
Smith (2021)
a Problem for Generations: Impact of E-Cigarette Type on Immune homeostasis.
Nonclinical
Immunotoxicity
In Vivo
Sullivan (2022)